Meprylcaine MCQs With Answer offers B. Pharm students a focused review of Meprylcaine’s pharmacology, clinical uses, and safety. This concise introduction and the following targeted questions cover mechanism of action, structure-activity relationships, onset/duration determinants, administration techniques, common adverse effects, monitoring, and practical tips for dosing and toxicity management. The set emphasizes core keywords such as Meprylcaine, local anesthetic, sodium channel blockade, pKa, lipid solubility, protein binding, vasoconstrictor interactions, CNS and cardiovascular toxicity, and lipid rescue. Each MCQ reinforces applied knowledge essential for pharmacy practice and exam preparation. Now let’s test your knowledge with 30 MCQs on this topic.
Q1. Which best describes Meprylcaine’s primary therapeutic action?
- Inhibition of cyclooxygenase enzymes
- Reversible blockade of voltage-gated sodium channels
- Activation of GABA receptors
- Antagonism of NMDA receptors
Correct Answer: Reversible blockade of voltage-gated sodium channels
Q2. The essential structural features common to local anesthetics like Meprylcaine include:
- Aromatic ring, intermediate ester/amide linkage, and a tertiary amine
- Peptide backbone with sulfhydryl group
- Benzodiazepine core and halogen substituents
- Steroid nucleus and polar head group
Correct Answer: Aromatic ring, intermediate ester/amide linkage, and a tertiary amine
Q3. Which factor most directly influences the onset of action of Meprylcaine?
- Half‑life of the drug
- pKa relative to physiological pH
- Degree of renal clearance
- Plasma protein binding
Correct Answer: pKa relative to physiological pH
Q4. Adding epinephrine to a Meprylcaine injection primarily results in:
- Increased systemic absorption and shorter duration
- Reduced analgesic potency at the site
- Local vasoconstriction that prolongs duration and reduces systemic absorption
- Direct blockade of sodium channels by epinephrine
Correct Answer: Local vasoconstriction that prolongs duration and reduces systemic absorption
Q5. The typical early central nervous system sign of local anesthetic systemic toxicity is:
- Profound hypotension without neurological signs
- Initial CNS excitation such as metallic taste and tinnitus followed by seizures
- Immediate coma without prior symptoms
- Isolated peripheral neuropathy
Correct Answer: Initial CNS excitation such as metallic taste and tinnitus followed by seizures
Q6. Which statement about the relationship between lipid solubility and local anesthetic potency is correct?
- Higher lipid solubility decreases potency
- Lipid solubility does not affect potency
- Higher lipid solubility increases potency and duration
- Only protein binding determines potency
Correct Answer: Higher lipid solubility increases potency and duration
Q7. In peripheral nerve blockade, local anesthetics like Meprylcaine typically block which fibers first?
- Large myelinated motor fibers first
- Small myelinated pain fibers first, then temperature, touch, and motor last
- Proprioceptive fibers first
- All fibers are blocked simultaneously regardless of size or myelination
Correct Answer: Small myelinated pain fibers first, then temperature, touch, and motor last
Q8. Which modification will speed the onset of Meprylcaine infiltration in acidic infected tissue?
- Adding alkalinizing agent (e.g., sodium bicarbonate)
- Lowering the pH further
- Decreasing the dose
- Co-administering a beta blocker
Correct Answer: Adding alkalinizing agent (e.g., sodium bicarbonate)
Q9. Reversible binding of Meprylcaine to which channel state explains use‑dependent block?
- Resting closed state only
- Open and inactivated states preferentially
- Calcium channels exclusively
- Potassium channels predominantly
Correct Answer: Open and inactivated states preferentially
Q10. Which clinical technique is NOT a standard route for local anesthetic administration?
- Peripheral nerve block
- Topical application
- Intravenous regional anesthesia (Bier block)
- Systemic oral tablet for surgical anesthesia
Correct Answer: Systemic oral tablet for surgical anesthesia
Q11. Which patient condition increases the risk of systemic toxicity from amide local anesthetics?
- Hepatic impairment due to reduced metabolism
- Hyperthyroidism enhancing clearance
- Enhanced plasma cholinesterase activity
- High red blood cell count
Correct Answer: Hepatic impairment due to reduced metabolism
Q12. Allergic reactions to local anesthetics are most commonly associated with which class and why?
- Amide class due to aromatic metabolites
- Ester class due to para-aminobenzoic acid (PABA) metabolites
- Amide class due to liver metabolites
- All local anesthetics are equally likely with no class difference
Correct Answer: Ester class due to para-aminobenzoic acid (PABA) metabolites
Q13. Which monitoring or rescue measure is indicated for severe systemic local anesthetic toxicity?
- Immediate intralipid (lipid emulsion) therapy along with standard resuscitation
- Defer resuscitation and observe for spontaneous recovery
- Only give oral activated charcoal
- Administer systemic corticosteroids as first-line
Correct Answer: Immediate intralipid (lipid emulsion) therapy along with standard resuscitation
Q14. Which property most contributes to a longer duration of action for Meprylcaine at the site of injection?
- Low lipid solubility and low protein binding
- High plasma clearance
- High protein binding and high lipid solubility
- Rapid renal excretion
Correct Answer: High protein binding and high lipid solubility
Q15. A useful step to minimize intravascular injection when administering Meprylcaine is:
- Aspirate before injection and inject incrementally with frequent aspiration
- Inject the entire dose rapidly without aspiration
- Always add more epinephrine to mask intravascular injection
- Give the drug only intramuscularly to avoid intravascular risk
Correct Answer: Aspirate before injection and inject incrementally with frequent aspiration
Q16. Which statement about pKa and nonionized fraction is correct for local anesthetic effectiveness?
- A local anesthetic with pKa much higher than physiological pH has a greater nonionized fraction at body pH
- A lower pKa relative to physiological pH increases the nonionized fraction and speeds onset
- pKa has no relation to ionization or onset
- Only protein binding determines the nonionized fraction
Correct Answer: A lower pKa relative to physiological pH increases the nonionized fraction and speeds onset
Q17. Which adverse cardiovascular effect is commonly associated with systemic overdose of local anesthetics?
- Cardiac excitation with tachyarrhythmias only
- Progressive myocardial depression, hypotension, and conduction block
- Hypertensive crisis without conduction changes
- Isolated peripheral vasospasm without myocardial effects
Correct Answer: Progressive myocardial depression, hypotension, and conduction block
Q18. For safe clinical use of Meprylcaine in outpatient procedures, which precaution is most appropriate?
- Use the maximum dose without consulting weight or comorbidities
- Assess patient history for allergies, calculate dose by weight, and monitor vital signs
- Skip aspiration to save time
- Never combine with vasoconstrictors under any circumstance
Correct Answer: Assess patient history for allergies, calculate dose by weight, and monitor vital signs
Q19. Which lab or bedside finding suggests early local anesthetic systemic toxicity?
- Bradykinesia and oliguria without neurological signs
- Tinnitus, circumoral numbness, and metallic taste
- Isolated rash at injection site only
- High-grade fever immediately after injection
Correct Answer: Tinnitus, circumoral numbness, and metallic taste
Q20. Which factor does NOT typically prolong the systemic elimination half‑life of an amide local anesthetic?
- Hepatic impairment
- Reduced hepatic blood flow
- Concurrent drugs that inhibit hepatic enzymes
- Increased plasma cholinesterase activity
Correct Answer: Increased plasma cholinesterase activity
Q21. Which statement about topical application of Meprylcaine is correct?
- Topical use always results in higher systemic exposure than injection
- Topical application provides localized anesthesia with variable absorption depending on mucosal integrity
- Topical application never causes systemic toxicity
- Topical Meprylcaine is ineffective on mucous membranes
Correct Answer: Topical application provides localized anesthesia with variable absorption depending on mucosal integrity
Q22. In the context of structure-activity relationships, which change generally increases potency of local anesthetics?
- Removal of the aromatic ring
- Increased lipophilicity of the aromatic moiety
- Conversion to a charged quaternary ammonium permanently
- Reducing molecular size to below 50 Da
Correct Answer: Increased lipophilicity of the aromatic moiety
Q23. When choosing a local anesthetic for a patient with known ester allergy, what is the safest general approach?
- Use another ester anesthetic with lower PABA production
- Prefer an amide local anesthetic after allergy assessment
- Always avoid all local anesthetics
- Use topical esters instead of injectable forms
Correct Answer: Prefer an amide local anesthetic after allergy assessment
Q24. Which monitoring is essential after high‑dose peripheral nerve block with Meprylcaine?
- No monitoring is required for peripheral blocks
- Continuous cardiovascular and neurological monitoring for at least 30–60 minutes
- Only measure urine output
- Monitor blood glucose only
Correct Answer: Continuous cardiovascular and neurological monitoring for at least 30–60 minutes
Q25. The phenomenon of tachyphylaxis (diminished effect on repeated administration) with local anesthetics is most often due to:
- Permanent nerve degeneration
- Local tissue acidosis and dispersion of drug away from nerve fibers
- Immediate immune-mediated neutralization
- Increased renal excretion during repeated dosing
Correct Answer: Local tissue acidosis and dispersion of drug away from nerve fibers
Q26. Which drug interaction concerning Meprylcaine raises concern for amplified cardiovascular toxicity?
- Concurrent use of local antacids
- Beta-blockers or other drugs that blunt compensatory sympathetic responses when combined with epinephrine-containing formulations
- Concurrent vitamin C supplementation
- Use of topical emollients at injection site
Correct Answer: Beta-blockers or other drugs that blunt compensatory sympathetic responses when combined with epinephrine-containing formulations
Q27. Which physical property of Meprylcaine most influences its diffusion through nerve sheaths?
- Water solubility only
- Lipid solubility and molecular size
- Color of the solution
- Optical rotation
Correct Answer: Lipid solubility and molecular size
Q28. Which clinical sign differentiates high spinal/epidural block from systemic toxicity after neuraxial Meprylcaine administration?
- Progressive motor block and hypotension with respiratory compromise, corresponding to high block level
- Tinnitus and metallic taste only
- Isolated erythema at injection site
- Urinary frequency without motor changes
Correct Answer: Progressive motor block and hypotension with respiratory compromise, corresponding to high block level
Q29. For educational dosing guidance, which practice is most important when calculating a safe Meprylcaine dose?
- Ignore patient weight if using topical application
- Calculate maximum recommended dose based on patient weight and co-morbidities and adjust for vasoconstrictor presence
- Always use a single fixed maximal dose for all adults
- Double the usual dose in elderly patients to ensure efficacy
Correct Answer: Calculate maximum recommended dose based on patient weight and co-morbidities and adjust for vasoconstrictor presence
Q30. Which educational point should be emphasized to patients receiving Meprylcaine for outpatient procedures?
- They can drive immediately after injection regardless of motor block
- Avoid chewing or biting numb areas, report unusual symptoms, and follow post-procedure activity restrictions until sensation returns
- Apply heat to injection site immediately to speed recovery
- Discontinue all other medications without consulting prescriber
Correct Answer: Avoid chewing or biting numb areas, report unusual symptoms, and follow post-procedure activity restrictions until sensation returns
